文献速递胃肠动力与功能性疾病

遗传性α-类胰蛋白酶血症与乳糜泻患者无麸质饮食下持续症状相关

Hereditary Alpha-Tryptasemia Is Associated With Ongoing Symptoms in Individuals With Celiac Disease Despite Following a Gluten-free Diet.
PubMed 文献 · Am J Gastroenterol · 2025-05-14

前瞻性队列纳入140例乳糜泻和13例非乳糜泻麸质敏感者,检测基线血清类胰蛋白酶和TPSAB1基因型。9例携带遗传性α-类胰蛋白酶血症者均为有症状的乳糜泻患者,其中6.4%为持续症状亚组占12.3%。作者认为对持续症状的乳糜泻患者可考虑评估该遗传特征。

要点

  • 乳糜泻患者中遗传性α-类胰蛋白酶血症患病率与一般人群相似。
  • 携带该特征的乳糜泻患者均有持续胃肠道症状。
  • 乳糜泻患者十二指肠肥大细胞计数高于对照,携带者再高24%。

核心结论

  • 乳糜泻中遗传性α-类胰蛋白酶血症患病率与一般人群相似,但所有携带该特征的乳糜泻患者均有持续胃肠道症状。
  • 作者认为对持续症状的乳糜泻患者管理时可考虑评估遗传性α-类胰蛋白酶血症。

研究设计与样本

  • 前瞻性队列纳入153例受试者,其中非乳糜泻麸质敏感13例、乳糜泻140例(新诊断8例、持续症状66例、临床缓解66例)。
  • 基线血清类胰蛋白酶用免疫分析法测定,TPSAB1基因型用微滴式数字PCR检测。
  • 十二指肠和胃活检组织行c-KIT染色,肥大细胞计数取5个高倍视野平均值。

主要发现

  • 9例检出遗传性α-类胰蛋白酶血症,均为有症状的乳糜泻患者(6.4%),其中1例新诊断、其余为持续症状(占该亚组12.3%)。
  • 排除遗传性α-类胰蛋白酶血症后,乳糜泻患者基线血清类胰蛋白酶中位数5.4 mcg/L高于非乳糜泻麸质敏感者的3.9 mcg/L(P < 0.05)。
  • 乳糜泻患者十二指肠肥大细胞计数高于对照(P < 0.05),携带遗传性α-类胰蛋白酶血症者再高24%(中位数:携带者乳糜泻27.3/hpf、非携带者乳糜泻22.0/hpf、对照18.4/hpf)。
  • 肥大细胞计数不因绒毛萎缩或临床表现不同而有差异。

临床怎么用

  • 作者认为,对持续症状的乳糜泻患者管理时可考虑评估遗传性α-类胰蛋白酶血症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hereditary alpha-tryptasemia (HαT) is caused by the increased copy number of TPSAB1 when encoding for alpha-tryptase, resulting in elevated basal serum tryptase (BST). Many affected individuals report irritable bowel syndrome-like and reflux symptoms. We aimed to assess the prevalence of HαT in celiac disease (CeD) and whether this genetic trait modifies disease course. METHODS: This study included a prospective cohort of subjects with CeD or nonceliac gluten sensitivity (NCGS) either at diagnosis (Dx), with persisting symptoms on a gluten-free diet, or in clinical remission. BST levels were determined by immunoassay, and tryptase genotyping was performed on genomic DNA using digital droplet polymerase chain reaction (PCR) [ddPCR]. Duodenal and gastric biopsies were stained for c-KIT, and mast cell (MC) counts were averaged over 5 high power field (hpf). RESULTS: There were 153 eligible subjects: 13 with NCGS and 140 with CeD (8 patients with new Dx, 66 with persisting symptoms, 66 in remission). HαT was found in 9 subjects, all symptomatic with CeD (6.4%). One was new Dx, and the others had persisting symptoms (12.3% of subgroup). Excluding HαT, BST levels were higher among patients with CeD vs NCGS (median 5.4 vs 3.9 mcg/L P < 0.05). Duodenal MC counts were higher in CeD vs controls ( P < 0.05) and 24% higher in those with HαT (median HαT CeD 27.3/hpf, non-HαT CeD 22.0/hpf, controls 18.4/hpf). MC counts did not differ based on villous atrophy or clinical presentation. DISCUSSION: The prevalence of HαT in CeD is similar to the general population; however, all participants with CeD and HαT had ongoing gastrointestinal (GI) symptoms. Evaluation for HαT should be considered in the management of patients with CeD and persisting symptoms.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Therrien A, Akula S, Galeas-Pena M, et al. Hereditary Alpha-Tryptasemia Is Associated With Ongoing Symptoms in Individuals With Celiac Disease Despite Following a Gluten-free Diet. Am J Gastroenterol. 2025. PMID: 40367491. doi:10.14309/ajg.0000000000003537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。